Doxycycline hyclate controlled release - POLYPID
Alternative Names: D-PLEX; D-PLEX100; Doxycycline/polymer-lipid encapsulation matrix; PLEX-doxycyclineLatest Information Update: 11 Oct 2023
At a glance
- Originator POLYPID
- Class Antibacterials; Collagenases; Skin disorder therapies; Tetracyclines
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Surgical wound infections
Most Recent Events
- 04 Oct 2023 Adverse events data from a preclinical study in Surgical wound infections released by POLYPID
- 22 May 2023 US FDA approves revised protocol for phase III SHIELD II trial for Postoperative infections (Prevention)
- 10 May 2023 PolyPid submits revised protocol for phase III SHIELD trial to US FDA